Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Comparing the PLCO and ERSPC trials on efficacy of prostate cancer screening

17th ECCO - 38th ESMO - 32nd ESTRO European Cancer Congress (ECC 2013)

Published: 3 Oct 2013

Views: 5185

Rating:

Save

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK

Prof Jack Cuzick talks to ecancer at the 2013 European Cancer Congress in Amsterdam about the role of prostate cancer screening and why two trials, European Randomized Study of Screening for Prostate Cancer (ERSPC) and the PLCO trial, came to different conclusions about its benefits.

Related Videos

Powering equity in cancer care through digital health

Dr Sanjeev Arora - Project ECHO, Albuquerque, USA

Powering equity in cancer care through digital health ( Dr Sanjeev Arora - Project ECHO, Albuquerque, USA )

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof...

ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2...

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )

Psychological issues in familial cancer

Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India

Psychological issues in familial cancer ( Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India )

Best practice in HRRm testing in patients with metastatic prostate cancer

Prof Martin Schostak, Dr Alexander Wyatt, Prof Charles Ryan and Dr Emmanuel...

Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Martin Schostak, Dr Alexander Wyatt, Prof Charles Ryan and Dr Emmanuel Antonarakis )

Genomic testing: Awareness and effective communication between healthcare...

Prof Richard Simcock and Antonella Cardone

Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )

A biomarker led approach to bladder cancer

Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr...

A biomarker led approach to bladder cancer ( Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr Yohann Loriot )

The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of...

Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina

The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer ( Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina )

iCCaRE Consortium for Black Men: Second Discussion

Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina

iCCaRE Consortium for Black Men: Second Discussion ( Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina )

More from ecancer